OxySure (OXYS) Announces Products Available in MSC Industrial "Big Book" and on mscdirect.com

OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a global
leader and medical device innovator of life-saving, easy-to-use emergency oxygen
solutions with its "oxygen from powder" technology is pleased to announce its
products are now immediately available on mscdirect.com, to be followed by
insertion in MSC Industrial's "Big Book." This includes the OxySure Model 615
emergency oxygen device, replacement cartridges, thermal bags, pulse oximeters
and other respiratory and emergency medical products.


The OxySure Model 615 enables lay persons, from bystanders to work colleagues,
to administer medical oxygen easily and quickly in any medical emergency, while
waiting for paramedics or first responders to arrive on the scene. Model 615 is
particularly suited as a companion product to Automated External Defibrillators
(AEDs), and is FDA cleared for over the counter purchase.


"We are pleased to be represented on mscdirect.com and in the MSC Industrial
catalog," said Julian T. Ross, CEO of OxySure. "Our products can enable good
outcomes and even save lives in medical emergencies in industrial settings such
as manufacturing facilities and commercial environments all over America."


About MSC Industrial Supply Co.

MSC Industrial Supply Co. is one of the largest distributors of metalworking and
maintenance, repair and operations ("MRO") supplies to industrial customers
throughout the United States. MSC employs one of the industry's largest sales
forces and distributes approximately 600,000 industrial products from
approximately 3,000 suppliers. In-stock availability is approximately 99%, with
next day standard delivery to the contiguous United States on qualifying orders
up until 8 p.m. Eastern Time. For more information, visit MSC's website at
mscdirect.com.


About OxySure Systems, Inc.

OxySure Systems, Inc. (OTCQB: OXYS) is a medical technology company that focuses
on the design, manufacture and distribution of specialty respiratory and medical
solutions. The company pioneered a safe and easy to use solution to produce
medically pure (USP) oxygen from inert powders. The company owns numerous issued
patents and patents pending on this technology which makes the provision of
emergency oxygen safer, more accessible and easier to use than traditional
oxygen provision systems. OxySure's products improve access to emergency oxygen
that affects the survival, recovery and safety of individuals in several areas
of need: (1) Public and private places and settings where medical emergencies
can occur; (2) Individuals at risk for cardiac, respiratory or general medical
distress needing immediate help prior to emergency medical care arrival; and (3)
Those requiring immediate protection and escape from exposure situations or
oxygen-deficient situations in industrial, mining, military, or other
"Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com


Forward-Looking Statements

This release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements contained in this
release that are not historical facts, including, without limitation, statements
that relate to the Company's expectations with regard to the future impact on
the Company's results from new products in development, may be deemed to be
forward-looking statements. Words such as "expects", "intends", "plans", "may",
"could", "should", "anticipates", "likely", "believes" and words of similar
import also identify forward-looking statements. These statements are subject to
risks and uncertainties. Forward-looking statements are based on current facts
and analyses and other information that are based on forecasts of future
results, estimates of amounts not yet determined and assumptions of management.
Readers are urged not to place undue reliance on the forward-looking statements,
which speak only as of the date of this release. Except as may be required under
applicable law, we assume no obligation to update any forward-looking statements
in order to reflect any event or circumstance that may arise after the date of
this release. Additional information on risks and other factors that may affect
the business and financial results of OxySure Systems, Inc. can be found in the
filings of OxySure Systems, Inc. with the U.S. Securities and Exchange
Commission.



FOR FURTHER INFORMATION PLEASE CONTACT: 

Investor Contact:
Stonegate Securities, Inc.
214-987-4121 / 972-294-6461
[e-mail] 

Media Contact:
[e-mail]